These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12877632)

  • 1. IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy.
    Paunio M; Hedman K; Davidkin I; Peltola H
    Expert Opin Pharmacother; 2003 Aug; 4(8):1215-25. PubMed ID: 12877632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.
    Pannuti CS; Morello RJ; Moraes JC; Curti SP; Afonso AM; Camargo MC; Souza VA
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):119-22. PubMed ID: 14715557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles Virus IgG Avidity Assay for Use in Identification of Measles Vaccine Failures in Tianjin, China.
    Ding YX; Mao NY; Zhang Y; Lei Y; Gao ZG; Xu WB; Zhang Y
    Biomed Environ Sci; 2019 Nov; 32(11):804-811. PubMed ID: 31910938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.
    Mercader S; Garcia P; Bellini WJ
    Clin Vaccine Immunol; 2012 Nov; 19(11):1810-7. PubMed ID: 22971778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles infection in persons with secondary vaccine failure, New York City, 2018-19.
    Iwamoto M; Hickman CJ; Colley H; Arciuolo RJ; Mahle CE; Deocharan B; Siemetzki-Kapoor U; Zucker JR; Rosen JB
    Vaccine; 2021 Sep; 39(38):5346-5350. PubMed ID: 34393016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles IgG Avidity Assay.
    Mercader S; Crooke S
    Methods Mol Biol; 2024; 2808():247-264. PubMed ID: 38743375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.
    Rosen JB; Rota JS; Hickman CJ; Sowers SB; Mercader S; Rota PA; Bellini WJ; Huang AJ; Doll MK; Zucker JR; Zimmerman CM
    Clin Infect Dis; 2014 May; 58(9):1205-10. PubMed ID: 24585562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines.
    de Souza VA; Pannuti CS; Sumita LM; de Andrade Júnior HF
    J Med Virol; 1997 Jul; 52(3):275-9. PubMed ID: 9210036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A measles outbreak from an index case with immunologically confirmed secondary vaccine failure.
    Kurata T; Kanbayashi D; Egawa K; Kinoshita M; Yoshida H; Miyazono M; Motomura K
    Vaccine; 2020 Feb; 38(6):1467-1475. PubMed ID: 31831219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.
    Atrasheuskaya AV; Kulak MV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2008 Apr; 26(17):2111-8. PubMed ID: 18343536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination coverage against measles and sero-epidemiology of measles-specific IgG antibodies in German children and adolescents].
    Poethko-Müller C; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1243-52. PubMed ID: 23990086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of measles specific IgM and IgG antibody detection in classification measles vaccine failure, Tianjin].
    Ding YX; Mao NY; Zhang Y; Gao ZG; Xu WW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 May; 53(5):508-512. PubMed ID: 31091610
    [No Abstract]   [Full Text] [Related]  

  • 15. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
    Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
    J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological and clinical characteristics of measles vaccine failure in Japan.
    Hidaka Y; Aoki T; Akeda H; Miyazaki C; Ueda K
    Scand J Infect Dis; 1994; 26(6):725-30. PubMed ID: 7747097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
    Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.